electroCore To Present At Major European Headache Meeting (EHMTIC) On The Success Of Its Non-Invasive Vagus Nerve Stimulation Therapy For Cluster Headache

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

This weekend, at the international headache meeting in Copenhagen (EHMTIC*), electroCore will be presenting full data on their PREVA study, a randomized, multi-center trial across several European countries, which showed that preventative use of non-invasive vagus nerve stimulation (nVNS) can substantially reduce the frequency of cluster headache attacks (i.e., by 43.4%) versus the control group (the current standard of care, which experienced only a 12% reduction).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC